Index by author

May 01, 2005; Volume 25,Issue 3A

Proccedings of the 12th International Hamburg Symposium on Tumor Markers, November 30 - December 2, 2003, Hamburg, Germany

  1. Akcetin, Z.

    1. Radiochemotherapy after Transurethral Resection is an Effective Treatment Method in T1G3 Bladder Cancer
      Z. AKÇETIN, J. TODOROV, E. TÜZEL, D.G. ENGEHAUSEN, F.S. KRAUSE, R. SAUER, K.M. SCHROTT and C. RÖDEL
      Anticancer Research May 2005, 25 (3A) 1623-1628;
    2. Does the Distance to Normal Renal Parenchyma (DTNRP) in Nephron-sparing Surgery for Renal Cell Carcinoma have an Effect on Survival?
      Z. AKÇETIN, V. ZUGOR, D. ELSÄSSER, F.S. KRAUSE, B. LAUSEN, K.M. SCHROTT and D.G. ENGEHAUSEN
      Anticancer Research May 2005, 25 (3A) 1629-1632;

  2. Akcetin, ZIYA

    1. Polymorphisms in the Human Progesterone Receptor (PGR) Gene of Two Human Prostate Adenocarcinoma Cell Lines
      DIRK G. ENGEHAUSEN, SABINE ENDELE, STEFFEN F. KRAUSE, TORSTEN RITH, KARL M. SCHROTT and ZIYA AKCETIN
      Anticancer Research May 2005, 25 (3A) 1607-1609;
    2. Polymorphisms of Human Androgen Receptor (hAR) Gene in Prostate Cancer Cell Lines PC-EW and PC-OR
      DIRK G. ENGEHAUSEN, F. STEFFEN KRAUSE, JOHANN FLEISCHMANN, ZIYA AKCETIN, KARL M. SCHROTT and SABINE ENDELE
      Anticancer Research May 2005, 25 (3A) 1611-1614;

  3. Akcetin, ZIYA Y.

    1. Heterogeneity in Prostate Cancer: Prostate Specific Antigen (PSA) and DNA Cytophotometry
      F. STEFFEN KRAUSE, GERHARD FEIL, KARL-HORST BICHLER, KARL M. SCHROTT, ZIYA Y. AKCETIN and DIRK G. ENGEHAUSEN
      Anticancer Research May 2005, 25 (3A) 1783-1785;

  4. Alberti, WINFIRED

    1. Combination of Immunomagnetic Enrichment with Multiplex RT-PCR Analysis for the Detection of Disseminated Tumor Cells
      VEIT ZIEGLSCHMID, CHRISTIANE HOLLMANN, BERTHA GUTIERREZ, WINFIRED ALBERTI, DARK STROTHOFF, EBERHARD GROSS and OLIVER BÖCHER
      Anticancer Research May 2005, 25 (3A) 1803-1810;

  5. Alicarte, JULIAN

    1. Pro-gastrin-releasing Peptide (ProGRP) in Patients with Benign and Malignant Diseases: Comparison with CEA, SCC, CYFRA 21-1 and NSE in Patients with Lung Cancer
      RAFAEL MOLINA, JOSE M. AUGE, XAVIER FILELLA, NURIA VIÑOLAS, JULIAN ALICARTE, JOSE M. DOMINGO and ANTONIO M. BALLESTA
      Anticancer Research May 2005, 25 (3A) 1773-1778;

  6. Auge, J.M.

    1. S-100β and MIA in Advanced Melanoma in Relation to Prognostic Factors
      J.M. AUGE, R. MOLINA, X. FILELLA, E. BOSCH, M. GONZALEZ CAO, S. PUIG, J. MALVEHY, T. CASTEL and A.M. BALLESTA
      Anticancer Research May 2005, 25 (3A) 1779-1782;

  7. Auge, JOSE M.

    1. CYFRA 21.1 in Patients with Cervical Cancer: Comparison with SCC and CEA
      RAFAEL MOLINA, XAVIER FILELLA, JOSE M. AUGÉ, ELVIRA BOSCH, AURELI TORNE, JAUME PAHISA, JOSE A. LEJARCEGUI, ANGELS ROVIROSA, BEGONA MELLADO, JAUME ORDI and ALBERT BIETE
      Anticancer Research May 2005, 25 (3A) 1765-1771;

  8. Auge, JOSE M.

    1. Pro-gastrin-releasing Peptide (ProGRP) in Patients with Benign and Malignant Diseases: Comparison with CEA, SCC, CYFRA 21-1 and NSE in Patients with Lung Cancer
      RAFAEL MOLINA, JOSE M. AUGE, XAVIER FILELLA, NURIA VIÑOLAS, JULIAN ALICARTE, JOSE M. DOMINGO and ANTONIO M. BALLESTA
      Anticancer Research May 2005, 25 (3A) 1773-1778;

  9. Babinsky, A.

    1. Further Evidence for Prolongation of Survival of Pancreatic Cancer Patients by Efficacy Orientated Sequential Polychemotherapy (EOSPC) Based on Serial Tumor Marker Determinations (CA 19-9/CEA)
      R. KLAPDOR, M. BAHLO and A. BABINSKY
      Anticancer Research May 2005, 25 (3A) 1687-1691;

  10. Backe, J.

    1. S100 as an Immunohistochemically-detected Marker with Prognostic Significance in Endometrial Carcinoma
      A. HONIG, N. SCHALLER, J. DIETL, J. BACKE and U. KAMMERER
      Anticancer Research May 2005, 25 (3A) 1747-1753;
« Previous (Pages : 1 2 3 4 5 6 ... 24) Next »
Back to top

In this issue